Equities

ScinoPharm Taiwan Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert
1789:TAI

ScinoPharm Taiwan Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (TWD)21.65
  • Today's Change-0.300 / -1.37%
  • Shares traded2.08m
  • 1 Year change-3.13%
  • Beta0.4403
Data delayed at least 20 minutes, as of Feb 11 2026.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow Back to Overview

In millions of TWD
(except for per share items)
Fiscal data as of Dec 31 2024202420232022
OPERATIONS
Net income413349438
Depreciation/depletion479454434
Non-Cash items(26)(26)(15)
Cash taxes paid, supplemental10610378
Cash interest paid, supplemental8.079.167.89
Changes in working capital(124)(553)(89)
Total cash from operations751231774
INVESTING
Capital expenditures(280)(268)(243)
Other investing and cash flow items, total(13)35(10)
Total cash from investing(293)(233)(254)
FINANCING
Financing cash flow items2.64(1.03)(1.3)
Total cash dividends paid(237)(285)(380)
Issuance (retirement) of stock, net------
Issuance (retirement) of debt, net(10)(55)66
Total cash from financing(245)(341)(315)
NET CHANGE IN CASH
Foreign exchange effects12(10)8.44
Net change in cash224(353)214
Net cash-begin balance/reserved for future use3,9424,2954,081
Net cash-end balance/reserved for future use4,1663,9424,295
SUPPLEMENTAL INCOME
Depreciation, supplemental479454434
Cash interest paid, supplemental8.079.167.89
Cash taxes paid, supplemental10610378
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.